Fig. 2
Consensus criteria anti-phospholipid antibodies detected by enzyme-linked immunosorbent assays (ELISAs) in 95 subjects including 34 patients with anti-phospholipid syndrome (APS), 41 with systemic autoimmune rheumatic disease (SARD) and no adverse APS events, as well as 20 healthy subjects (children) (HS) as control group. aβ2GPI anti-beta2-glycoprotein I, aCL anti-cardiolipin